Psychology & Psychiatry

Common antibiotic may help to prevent or treat PTSD

The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.

Diseases, Conditions, Syndromes

Study discloses new test for river blindness infection

Scientists at The Scripps Research Institute (TSRI) have found a telltale molecular marker for Onchocerciasis or "river blindness," a parasitic infection that affects tens of millions of people in Africa, Latin America and ...

Neuroscience

Gene therapy for hearing loss: Potential and limitations

Regenerating sensory hair cells, which produce electrical signals in response to vibrations within the inner ear, could form the basis for treating age- or trauma-related hearing loss. One way to do this could be with gene ...

Diseases, Conditions, Syndromes

US syphilis cases continue to climb

U.S. cases of syphilis have soared past numbers seen just a decade ago, new government statistics show. The grim numbers are for 2022, the latest year for which an accurate tally is available.

Medications

Q&A: DoxyPEP, a 'morning-after pill' for STIs

There has been an alarming increase in sexually transmitted infections in the U.S. over the past decade: In 2021 alone, 2.53 million cases of chlamydia, gonorrhea, and syphilis were recorded, a 7% increase from 2017—and ...

Medications

Combined antibiotics more effective against Lyme disease: Study

Researchers at Tulane University have found that a combination of antibiotics is more effective in treating Lyme disease than the commonly prescribed course of one single antibiotic. This finding, published in Frontiers in ...

page 1 from 4

Doxycycline

Doxycycline INN ( /ˌdɒksɨˈsaɪkliːn/ doks-i-sy-kleen) is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. Doxycycline is a semisynthetic tetracycline invented and clinically developed in the early 1960s by Pfizer Inc.[citation needed] and marketed under the brand name Vibramycin.[citation needed] Vibramycin received U.S. Food and Drug Administration (FDA) approval in 1967,[citation needed] becoming Pfizer's first once-a-day, broad-spectrum antibiotic.[citation needed] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx, Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral,Doxy-1 and Atridox (topical doxycycline hyclate for periodontitis).

This text uses material from Wikipedia, licensed under CC BY-SA